Galera Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.83 | $0.83 | $0.83 |
| Q2 2024 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q3 2024 | 1 | -$0.30 | -$0.30 | -$0.30 |
Galera Therapeutics, Inc. Earnings Date And Information
Galera Therapeutics, Inc. last posted its earnings results on Tuesday, November 14th, 2023. The company reported $-0.33 earnings per share for the quarter, topping analysts' consensus estimates of $-0.44 by $0.11. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Galera Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.33 diluted earnings per share) and currently has a price-to-earnings ratio of -0.07. Galera Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based on prior year's report dates.
Galera Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.07 | $50.00 M | $0 | ||
| 05/13/2024 | Q1 2024 | -$0.08 | $0 | |||
| 03/28/2024 | Q4 2023 | -$0.10 | $88,000 | |||
| 09/29/2023 | Q3 2023 | -$0.33 | $0 | |||
| 08/14/2023 | Q2 2023 | -$0.43 | -$0.48 | -0.05 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.36 | -$0.73 | -0.37 | $0 | |
| 03/08/2023 | Q4 2022 | -$0.50 | -$0.58 | -0.08 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.48 | -$0.71 | -0.23 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.47 | -$0.64 | -0.17 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.53 | -$0.66 | -0.13 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.75 | -$0.64 | 0.11 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.65 | -$0.86 | -0.21 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.79 | -$0.88 | -0.09 | $0 | |
| 05/11/2021 | Q1 2021 | -$0.82 | -$0.75 | 0.07 | $0 | |
| 03/11/2021 | Q4 2020 | -$0.66 | -$0.80 | -0.14 | $0 | |
| 11/10/2020 | Q3 2020 | -$0.77 | -$0.69 | 0.08 | $0 | |
| 08/10/2020 | Q2 2020 | -$0.75 | -$0.75 | 0 | $0 | |
| 05/12/2020 | Q1 2020 | -$0.70 | -$0.74 | -0.04 | $0 | |
| 03/10/2020 | Q4 2019 | -$0.55 | -$1.24 | -0.69 | $0 | |
| 12/10/2019 | Q3 2019 | -$0.55 | $0 |
Galera Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Galera Therapeutics, Inc.'s earnings date?
Galera Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 25th, 2024 based off last year's report dates.
-
Did Galera Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Galera Therapeutics, Inc. (:GRTX) reported $-0.33 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.44 by $0.11.
-
How can I listen to Galera Therapeutics, Inc.'s earnings conference call?
The conference call for Galera Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Galera Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Galera Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Galera Therapeutics, Inc. generate each year?
Galera Therapeutics, Inc. (:GRTX) has a recorded net income of $0. Galera Therapeutics, Inc. has generated $-1.33 earnings per share over the last four quarters.
-
What is Galera Therapeutics, Inc.'s price-to-earnings ratio?
Galera Therapeutics, Inc. (:GRTX) has a price-to-earnings ratio of -0.07 and price/earnings-to-growth ratio is -0.
